PRESS RELEASE published on 05/16/2023 at 12:45, 3 years 2 months ago NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
PRESS RELEASE published on 04/25/2023 at 12:45, 3 years 3 months ago NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient
PRESS RELEASE published on 04/17/2023 at 12:45, 3 years 3 months ago NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
PRESS RELEASE published on 04/04/2023 at 13:45, 3 years 3 months ago NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates
PRESS RELEASE published on 02/15/2023 at 12:30, 3 years 5 months ago NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials
PRESS RELEASE published on 01/04/2023 at 12:35, 3 years 6 months ago NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
Published on 07/28/2026 at 16:55, 3 hours 30 minutes ago Unusual Machines Announces Record Date for 2026 Annual Meeting
Published on 07/28/2026 at 15:00, 5 hours 25 minutes ago Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Published on 07/28/2026 at 14:45, 5 hours 40 minutes ago Trifecta Gold Introduces the Liam and Lois Projects, East-Central Yukon and Grants Stock Options
Published on 07/28/2026 at 14:30, 5 hours 55 minutes ago Sekur Private Data Reports 25% Month-Over-Month Increase in Average Revenue Per User as Premium Pivot Takes Hold
Published on 07/28/2026 at 19:49, 36 minutes ago Medios AG: Earnings guidance for the financial year 2026 reduced – revenue guidance raised at the same time
Published on 07/28/2026 at 19:40, 44 minutes ago EQS-Adhoc: Medios AG: Adjusted guidance for the financial year 2026
Published on 07/28/2026 at 18:52, 1 hour 32 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE AG’s Preliminary Half-Year Results Exceed Market Expectations, Earnings Forecast for Financial Years 2026 and 2027 Raised
Published on 07/28/2026 at 18:30, 1 hour 55 minutes ago EUROPLASMA: Report de l’assemblée générale ordinaire et extraordinaire des actionnaires
Published on 07/28/2026 at 19:21, 1 hour 4 minutes ago Saint-Gobain signs a framework agreement with Microsoft and enhances its leadership in AI for construction
Published on 07/28/2026 at 19:21, 1 hour 4 minutes ago Saint-Gobain signe un accord-cadre avec Microsoft et renforce son leadership dans l’Intelligence Artificielle pour la construction
Published on 07/28/2026 at 18:25, 2 hours ago ACCOR - Finalisation de la 1ere tranche du programme de rachat d'action
Published on 07/28/2026 at 18:25, 2 hours ago ACCOR - Completion of the 1st tranche of the share buyback programme
Published on 07/28/2026 at 18:00, 2 hours 25 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/06/2026
